Understanding Calcium Hydroxylapatite (Radiesse) Fillers

Last updated: 11 February 2026

Calcium hydroxylapatite (CaHA), commercially available as Radiesse, is a unique injectable filler that occupies a distinctive position in the aesthetic practitioner’s toolkit. Unlike hyaluronic acid fillers that provide volume through a hydrophilic gel, Radiesse offers both immediate structural volumisation and long-term collagen biostimulation. This dual mechanism makes it particularly valuable for specific indications where structural support and skin quality improvement are both desired. This guide provides a thorough exploration of CaHA fillers for patients considering this treatment option in the United Kingdom.

What Is Calcium Hydroxylapatite?

Calcium hydroxylapatite is a naturally occurring mineral that constitutes the primary component of human bones and teeth. In its injectable form (Radiesse), CaHA microspheres (25-45 micrometres in diameter) are suspended in a carboxymethylcellulose (CMC) gel carrier. The microspheres are smooth, uniform, and non-toxic, and because CaHA is a substance naturally found in the body, the risk of allergic reaction is extremely low — no skin testing is required before treatment.

Radiesse was first CE-marked in Europe in 2004 and has since become one of the most widely used biostimulatory fillers globally. It holds regulatory approvals in over 80 countries and has an extensive safety record spanning nearly two decades of clinical use.

Dual Mechanism of Action

Immediate Volumisation

Upon injection, the CMC gel carrier provides immediate volume correction. This gel has a smooth, cohesive consistency that lifts and supports tissue effectively. The CaHA microspheres within the gel provide structural scaffolding, creating a framework that gives the filler excellent lifting capacity — particularly valuable in areas requiring strong structural support such as the jawline and cheeks.

Long-Term Biostimulation

Over the following weeks and months, the CMC gel carrier is gradually absorbed by the body. As it dissipates, the CaHA microspheres remain, stimulating a controlled tissue response. Fibroblasts are recruited to the area and begin producing new collagen around and between the microspheres. This neocollagenesis (new collagen formation) replaces the volume initially provided by the gel carrier with the patient’s own collagen tissue.

Eventually (over 12-18 months), the CaHA microspheres themselves are metabolised — broken down into calcium and phosphate ions that are naturally eliminated through normal metabolic pathways. The collagen framework that has formed around them persists, providing sustained structural support.

Phase	Timeline	What Happens	Clinical Effect
Immediate	Day 0	CMC gel provides volume; CaHA scaffolds	Instant lift and correction
Transition	Weeks 2-8	Gel absorbs; collagen production begins	Mild volume reduction then stabilisation
Biostimulation	Months 2-6	Active neocollagenesis around microspheres	Progressive skin quality improvement
Maturation	Months 6-18	CaHA metabolised; collagen persists	Natural-feeling, long-lasting correction

Treatment Areas

Face

Radiesse is particularly well-suited for areas requiring structural support and definition. The jawline benefits from Radiesse’s superior lifting capacity, with the firm consistency providing definition and projection that can rival surgical jawline implants for mild-to-moderate correction. Cheeks receive excellent volumisation and projection, and the biostimulatory effect improves skin quality in the overlying tissue. Chin augmentation is addressed effectively, providing both immediate projection and long-term collagen support. Marionette lines and nasolabial folds respond well, with the structural properties lifting deep folds from beneath. Temples can be filled to address the hollowing associated with ageing.

Hyperdilute Radiesse for Skin Quality

A significant development in CaHA treatment is the use of hyperdilute Radiesse for skin biostimulation. By diluting the product with saline and/or lidocaine, the CaHA microspheres are spread across a larger area, creating a diffuse collagen-stimulating effect without significant volumisation. This technique is used for skin laxity and crepiness in the neck, décolletage, and upper arms, hand rejuvenation (improving skin thickness, quality, and reducing visible veins and tendons), above-knee skin laxity, and facial skin quality improvement without additional volume.

Hyperdilute Radiesse has become one of the most innovative applications in modern aesthetic medicine, offering skin quality improvement in areas where few other treatments are effective.

Radiesse vs. Hyaluronic Acid Fillers

Understanding when to choose Radiesse over hyaluronic acid fillers — and vice versa — is crucial for optimal treatment planning. Radiesse provides superior structural support due to its higher G prime (elasticity), making it preferable for lifting and contouring. It lasts longer (12-18+ months vs. 6-18 months for most HA fillers). It stimulates native collagen production. It cannot be dissolved (unlike HA fillers, which can be reversed with hyaluronidase). It is not suitable for the lips (the firm consistency and lack of reversibility make lips an inappropriate site).

Hyaluronic acid fillers are preferred for the lips, tear trough, and areas requiring very precise, superficial placement. They offer reversibility, which provides an important safety net. They are more versatile, with multiple viscosities available for different indications.

Many experienced practitioners use both types of filler within the same treatment plan — Radiesse for structural areas such as jawline and cheeks, and HA fillers for lips, tear troughs, and fine lines.

The Treatment Experience

Consultation

A thorough consultation assesses facial structure, areas of concern, medical history, and treatment goals. The practitioner will discuss whether Radiesse, HA filler, or a combination approach is most appropriate. Key considerations include the desired outcome, the areas to be treated, the patient’s comfort with non-reversible products, and any previous filler treatments.

Procedure

The treatment takes 30-45 minutes. Radiesse contains integral lidocaine for patient comfort. Additional topical anaesthetic may be applied. The product is typically injected using a cannula for deep placement (reducing bruising risk) or a needle for precise superficial applications. The practitioner moulds the product after injection to ensure smooth, even distribution.

Recovery

Mild swelling and bruising are common, typically resolving within 5-7 days. The treatment area may feel firm initially but softens over the following 2-4 weeks. Patients are advised to avoid strenuous exercise for 48 hours, avoid excessive heat (saunas, hot baths) for 2 weeks, and avoid dental procedures for 2 weeks after lower face treatment.

Safety Profile

Radiesse has an extensive safety record. The most common side effects are injection-related: swelling, bruising, redness, and tenderness. Serious complications are rare but can include vascular occlusion (a risk shared with all injectable fillers), nodule formation (minimised by proper injection technique and appropriate depth), and migration (very rare with correct placement). The non-reversibility of Radiesse means that complication management differs from HA fillers — hyaluronidase cannot be used to dissolve the product. This underscores the importance of choosing an experienced, qualified practitioner.

Cost Considerations

In the UK, Radiesse treatment costs approximately £350-£600 per 1.5ml syringe. Most facial treatments require 1-3 syringes depending on the areas treated and degree of correction needed. Hyperdilute Radiesse for hands or body typically costs £300-£500 per treatment area. Whilst the per-syringe cost is comparable to premium HA fillers, the longer duration of Radiesse results (12-18+ months) means the annual cost of treatment is often lower.

Frequently Asked Questions

Related reading: Botox vs Dermal Fillers | Understanding Sculptra for Collagen Stimulation | Understanding Facial Volume Loss